Insulet | 资产

股票价格
246.61
每天变化
-4.89 -1.94%
每月一次
-4.49%
每年
-9.42%
Q1 预测
234.39


金融业
股票价格
USD
资产
USD 3.19B
现金及等价物
USD 716.1M
销售成本
USD 215.2M
流动资产
USD 1.91B
流动负债
USD 680.1M
债务
USD 1.01B
EBIT
USD 146.3M
EBITDA
USD 194M
员工
3.9K
EPS每股收益
USD 1.44
股本和储备
USD 1.52B
销售毛利
USD 568.6M
债务利息支出
USD 9.2M
利息收入
USD 8.6M
贷款资金
USD 930.8M
市值
USD 17.53B
净收入
USD 101.6M
营业费用
USD 637.5M
营业利润
USD 146.3M
普通股股本
USD 70.35M
PE价格收益
USD 55.08
税前利润
USD 140.2M
销售收入
USD 783.8M
销售和管理费用
USD 331.4M
股票
USD 452.6M
贸易债权人
USD 75M
应收帐款人
USD 516.9M


资产 更改 日
Abbott USD 86.71B 2.53B 2025-12
Align Technology USD 6.23B 141K 2025-12
AtriCure USD 654.18M 18.74M 2025-12
Avanos Medical USD 1.07B 6M 2025-12
Baxter International USD 20.06B 1.01B 2025-12
Becton, Dickinson and Co. USD 54.84B 484M 2025-12
Boston Scientific USD 43.67B 966M 2025-12
Cardinal Health USD 58.08B 2.86B 2025-12
Cooper Companies USD 12.39B 18.1M 2025-09
Dexcom USD 6.34B 1.16B 2025-12
Edwards Lifesciences USD 13.27B 216.5M 2025-09
Eli Lilly USD 112.48B 2.46B 2025-12
Globus Medical USD 5.3B 207.12M 2025-12
ICU Medical USD 4.05B 52.39M 2025-12
Inogen USD 307.01M 5.03M 2025-09
Insulet USD 3.19B 161.1M 2025-12
Integra LifeSciences USD 3.6B 44.45M 2025-12
J&J USD 199.21B 6.39B 2025-12
Masimo USD 1.82B 585.1M 2025-09
Medtronic USD 91.35B 374M 2025-09
Merit Medical Systems USD 2.69B 54.92M 2025-12
Roche Holding CHF 100.7B 5.94B 2025-12
Solventum Corp USD 14.29B 321M 2025-12
Stryker USD 47.84B 787M 2025-12
Tandem Diabetes Care USD 881.11M 6.46M 2025-12
Teleflex USD 6.95B 924.7M 2025-12
West Pharmaceutical Services USD 4.27B 164.2M 2025-12
Zimmer Biomet Holdings USD 23.09B 396.3M 2025-12


Insulet 资产 - 当前值，历史数据，预测，统计，图表和经济日历 - Feb 2026.